Janux Therapeutics’ $60 Million Offering of Common Stock and Pre-Funded Warrants

Pietro Martinoia
Tagged:

Cooley advised Janux, and Latham & Watkins advised the underwriter on the offering.Janux Therapeutics, Inc. (Nasdaq: JANX) has announced the pricing of an underwritten offering of 4,153,717…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here